BTAI
BioXcel Therapeutics Inc
NASDAQ: BTAI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.04
-1.89% today
Updated 2026-04-29
Market cap
$28.70M
P/E ratio
—
P/S ratio
44.70x
EPS (TTM)
$-5.73
Dividend yield
—
52W range
$1 – $8
Volume
1.8M
BioXcel Therapeutics Inc (BTAI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-280000.00 | $-1.29M | $-2.20M | $-13.51M | $-27.28M | $-66.35M | $-82.15M | $-135.34M | $-155.01M | $-72.03M | $-57.62M |
| Capital expenditures | $1000.00 | $4000.00 | $340000.00 | $340000.00 | $870000.00 | $316000.00 | $445000.00 | $139000.00 | $20000.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $671000.00 | $1.61M | $3.08M | $3.14M | $14.61M | $19.45M | $17.34M | $18.61M | $6.16M | $2.77M |
| Free cash flow | $-281000.00 | $-1.30M | $-2.54M | $-13.85M | $-28.15M | $-66.67M | $-82.60M | $-135.48M | $-155.03M | $-72.03M | $-57.62M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $41.68M | $-10.14M | $180.69M | $19.85M | $-39.24M | — | — | — |